AceLink Therapeutics vs HemoShear Therapeutics

AceLink Therapeutics logo

AceLink Therapeutics

Overcome genetic diseases, one at a time

4 employees · est. 2019 · Newark, United States

VS
HemoShear Therapeutics logo

HemoShear Therapeutics

Developing new treatments for rare metabolic disorders

27 employees · est. 2008 · Charlottesville, United Stat...

HemoShear Therapeutics is the older company (2019 vs 2008); HemoShear Therapeutics is the larger of the two.

Side-by-Side Comparison

AceLink Therapeutics HemoShear Therapeutics
Founded
2019 2008 older
Headquarters
Newark, United States Charlottesville, United States
Employees
4 27 larger
Industry
Not tracked yet Biotechnology, Health Care
Funding Stage
Venture round Debt Financing
Total Funding
Not tracked yet $54.95M
Funding Rounds
1 8
Taxonomy
BiopharmaceuticalStartupDrug DevelopmentGenetic DiseasesSmall Molecule DrugsPolycystic Kidney Disease +2 Drug DiscoveryMetabolic DisordersRare DiseasesHuman Disease ModelsTissue EngineeringPharmaceutical Partnerships +4
Website
acelinktherapeutics.com hemoshear.com
AceLink Therapeutics logo

About AceLink Therapeutics

AceLink Therapeutics is a biopharmaceutical startup based in the San Francisco Bay Area, founded in 2019. The company's mission is to develop innovative drugs to combat genetically associated human diseases. Their initial focus is on creating a small molecule drug for polycystic kidney disease (PKD)...

HemoShear Therapeutics logo

About HemoShear Therapeutics

HemoShear Therapeutics is a biotechnology company with a focus on developing new treatments for rare metabolic disorders. Established in 2008, the company utilizes a proprietary technology that allows them to recapitulate diseases using tissue from livers of children born with genetic defects. This...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches AceLink Therapeutics and HemoShear Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when AceLink Therapeutics or HemoShear Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

AceLink Therapeutics was founded in 2019, based in Newark, United States, with 4 employees. AceLink Therapeutics is a biopharmaceutical startup based in the San Francisco Bay Area, founded in 2019. The company's mission is to develop innovative drugs to combat genetically associated human di. HemoShear Therapeutics was founded in 2008, based in Charlottesville, United States, with 27 employees. HemoShear Therapeutics is a biotechnology company with a focus on developing new treatments for rare metabolic disorders. Established in 2008, the company utilizes a proprietary technology that allows.
AceLink Therapeutics has raised no disclosed funding and HemoShear Therapeutics $54.95M. Latest stage: AceLink Therapeutics Venture round, HemoShear Therapeutics Debt Financing.

Compare AceLink Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at AceLink Therapeutics on 12 Sep 2024, and HemoShear Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes